BMJ 1994;309:126 (9 July)
Letters
Patients are unwilling to enter randomised trials
EDITOR,--The Medical Research Council is carrying out a trial comparing chemotherapy and surgery versus surgery alone in oesophageal carcinoma. Of the last six patients with oesophageal cancer with whom I have discussed this trial, only one has agreed to be randomised. The remaining five declined because they were not willing to risk a possible delay of six to eight weeks to their surgery should they have been randomised to the chemotherapy arm or because of disquiet over the possible side effects of chemotherapy during a period of natural anxiety before they underwent major surgery.
These genuine anxieties may well account for some of the poor rates of accrual to trials of treatment of oesophageal cancer.1
T C B Dehn
Consultant surgeon Royal Berkshire Hospital, Reading RG1 5AN.
1 O'Reily S, Forastiere A. New approaches to treating oesophageal cancer. BMJ 1994;308:1249-50. (14 May.)[Full Text]